Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251

benzinga.com/general/biotech/25/03/44174322/cancer-focused-zymeworks-q4-earnings-miss-expectations-reprioritize-resources-to-focus-on-zw251

On Wednesday, Zymeworks Inc. (NASDAQ:ZYME) released fourth-quarter financial results. The company reported an earnings loss of 31 cents per share, missing the consensus loss of 3 cents.
Sales came at $31.03 million, missing the consensus of $45.2 million.
In its fourth-quarter earnings…

This story appeared on benzinga.com, 2025-03-06 18:18:27.